Navigation Links
China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009
Date:11/13/2008

SHENZHEN CITY, China, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- China Information Security Technology, Inc., (Nasdaq: CPBY) ("China Information Security," "CIST" or the "Company"), a leading application software developer, systems integrator and full-service Geographic Information Systems ("GIS") solutions provider to public security and civil-use markets in China, today issued guidance for 2009.

China Information Technology has targeted revenue for 2009 of $107.5 million, an increase of approximately 26.5% from the stated goal of $85.0 million in the year 2008. Pro-forma net income is estimated at $32.9 million for 2009, representing a 21.9% increase from the Company's target of $27.0 million for 2008. Pro-forma earnings per share is estimated at $0.70 for 2009, up 25% from the Company's earnings per share target of $0.56 for 2008. The estimated pro-forma net income and earnings per share estimates for 2008 and 2009 exclude any non-cash expenses as a result of employee stock awards in 2008 and 2009 and amortization of intangible assets associated with recent acquisitions.

The Company expects to maintain a healthy growth rate through 2009 despite the current economic slowdown worldwide due to the end markets it serves. In November, China's State Economic Council unveiled a stimulus plan of approximately $586 billion for infrastructure projects aimed at boosting domestic demand.(1) In addition, the Guangdong Provincial Development and Reform Commission has indicated that Guangdong Province will spend $347 billion in the next five years to stimulate demand.(2) The Company's product mix is positioned to target city infrastructure planning so these recent announcements should work to its benefit. More important, the Company expec
'/>"/>

SOURCE China Information Security Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Newswire/--XiotechCorporationtodayannouncedthatMas...000storagesystem,poweredbyIntelligentStorageElemen...eneeds,enablefuturegrowthanddeliversignificantcapi...r. ,, MasonGeneral,locatedinShelton,Wash.,wasra...ostWired-Rural"hospitalsin2008and2009foritssuperio...
(Date:11/23/2009)...e/--Thanksgivingweekendmarksthe36thannualStateFarm...representsthesportsmanshipandprideoftwoschoolsbuti...seinattendance. ,, ForthecrewofthenewU.S.CoastG...beforetheyworktotestandlaunchabrandnewshiptoprotec...yOfficerClaudeBovellandtherestofthecrewwillbeginte...
(Date:11/23/2009)...g flaxseed oil to the diet could reduce the risk o...with diabetes, according to a report to be publish...utrition and Public Health . , Mer Harvi and col... Egypt, have studied the effect of diabetes on bon...t might delay the onset of osteoporosis. The resea...
(Date:11/23/2009)...ly modified to produce bacterial proteins that are...ve been planted on more than 200 million hectares ... after the bacterium Bacillus thuringiensis , com...lowing farmers to save money and lessen environmen...wever, since insects can evolve resistance to toxi...
(Date:11/23/2009)...prove patient outcomes, research suggests , ...mbination drug therapy shows promise in treating p...rchers say. , The study from the Massachusetts ...t survival and tumor response in patients treated ...tor that has helped slow the growth of other cance...
Breaking Medicine News(10 mins):Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Nothing Is Like Being There 2Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2
...cks colorectal cancer in mice , Non-steroidal an...d ibuprofen, and drugs that selectively target a p...ntestinal polyps, the precursors of colorectal can...ers, at Vanderbilt University School of Medicine, ...
...ct Judge Edward R. Korman ordered the FDA to make ...nor girls without a physician,s visit or prescript...so asked the FDA to consider making the drug avail...Council , s Senior Fellow for Regulatory Affairs, ...
...ream Flights Plus Card™ Sales to be Donated ... Opportunity to Receive Special Privileges and Ser...eatment for Pediatric Patients , ...Hospital. Through the use of the Dream Flights Plu...
...erve as Non-Executive Chairman of the Board - , ,...aq: GPRO ) announced today that its board of dir...chief executive officer (CEO), effective May 18, 2...fficer, will become president and CEO following th...
...maceuticals (Nasdaq: ENDP ) today announced the ...s Pharmaceuticals, Inc. Endo acquired Indevus thr...ch Indevus became a wholly owned subsidiary of End...are in cash and up to an additional $3.00 per shar...
...ince 1995 Targets Burgeoning German Demand for Hea...f., March 23 VeriFone Holdings, Inc. (NYSE: PAY...et growing demand in Germany for electronic health...of experience to meet the needs of healthcare orga...
Other Medicine News:Health News:JCI table of contents: March 23, 2009 2Health News:JCI table of contents: March 23, 2009 3Health News:JCI table of contents: March 23, 2009 4Health News:JCI table of contents: March 23, 2009 5Health News:JCI table of contents: March 23, 2009 6Health News:JCI table of contents: March 23, 2009 7Health News:JCI table of contents: March 23, 2009 8Health News:JCI table of contents: March 23, 2009 9Health News:Dream Flights Luxury Travel, Inc. and St. Jude Children's Research Hospital Join Forces to Find Cures and Save Children 2Health News:Dream Flights Luxury Travel, Inc. and St. Jude Children's Research Hospital Join Forces to Find Cures and Save Children 3Health News:Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer 2Health News:Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer 3Health News:Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals 2Health News:VeriFone eHealth Initiative Extends German Market Presence 2Health News:VeriFone eHealth Initiative Extends German Market Presence 3
(Date:11/23/2009)...O,Calif.,Nov.23/PRNewswire-FirstCall/--Anesiva,Inc...r.DavidC.U,PrichardhaveagreedtojointheAnesivaboard...etweenAnesivaandArcionTherapeutics.Completionofthe...aceatthepreviouslyannouncedAnesiva2009AnnualMeetin...PSTat400OysterPoint,Suite107A,SouthSanFrancisco,Ca...
(Date:11/23/2009)...v.23/PRNewswire-FirstCall/--RaptorPharmaceuticalCo...nouncedresultsfromaPhase2bclinicaltrialofitspropri...mine")inpatientswithnephropathiccystinosis("cystin...ia,SanDiego("UCSD")GeneralClinicalResearchCenter,e...rmacodynamicsofasingledoseofDRCysteamineinninecyst...
(Date:11/23/2009)...AZER,Pa.,Nov.23/PRNewswire-FirstCall/--CeptionTher...ny,andCephalon,Inc.(Nasdaq: CEPH )todayannouncedre...reslizumab)asatreatmentforpediatriceosinophiliceso...mentintheco-primaryendpointsofchangesinesophageale...taindicatedthatpatientstreatedwithCINQUILshowedast...
Breaking Medicine Technology:Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4FDA Investigating Safety of Asthma Drug Xolair 51948 1FDA Investigating Safety of Asthma Drug Xolair 51948 2Does Your Child Need Vision Therapy 3F 51946 1Does Your Child Need Vision Therapy 3F 51946 2Does Your Child Need Vision Therapy 3F 51946 3Does Your Child Need Vision Therapy 3F 51946 4Cogdell Spencer ERDMAN 28SM 29 Announces the Signing of Contracts Totaling 2488 8 Million in Janesville Wisconsin 51944 1Cogdell Spencer ERDMAN 28SM 29 Announces the Signing of Contracts Totaling 2488 8 Million in Janesville Wisconsin 51944 2Cogdell Spencer ERDMAN 28SM 29 Announces the Signing of Contracts Totaling 2488 8 Million in Janesville Wisconsin 51944 3
... Pharmaceutical,Research & Development, L.L.C. (J&...nstrate doripenem (DORIBAX(TM), doripenem for inje...ore potent in vitro against certain,strains of Ent...lactamases,(ESBLs) than other commonly used carbap...cteria that can cause,infections of the digestive ...
...ments in Productivity, Quality of Life and Lessen...can College of Rheumatology (ACR) Annual Sc... PST -- UCB announced,today results from several P...tolizumab pegol) - the only PEGylated anti-TNF (Tu...ollege of Rheumatology (ACR) Annual Scientific,Mee...
Other Medicine Technology:New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 2New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 3New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 4New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 2CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 3CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 4CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 6CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 7CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 8CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 9CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 10
TME 61 C
TME 60 S
...for traditional Lasik, Epi-Lasik and anterior and ...f rapidly changing technologies and applications i... remains a proven value, offering surgeons a platf... stay abreast of evolving technologies while prote...
...maging device that provides direct cross sectional...d subjective clinical evaluation in the detection ...mages and analyzes macular thickness, the retinal ...est technology for high resolution scans., ,S...
Medicine Products: